A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid

8.6K views

DOI:

10.3791/59034

February 27th, 2019

In This Article

Summary

This protocol describes an efficient method to synthesize a nanoemulsion of an oleic acids-platinum(II) conjugate stabilized with a lysine-tyrosine-phenylalanine (KYF) tripeptide. The nanoemulsion forms under mild synthetic conditions via self-assembly of the KYF and the conjugate.

Abstract

We describe a method to produce a nanoemulsion composed of an oleic acids-Pt(II) core and a lysine-tyrosine-phenylalanine (KYF) coating (KYF-Pt-NE). The KYF-Pt-NE encapsulates Pt(II) at 10 wt. %, has a diameter of 107 ± 27 nm and a negative surface charge. The KYF-Pt-NE is stable in water and in serum, and is biologically active. The conjugation of a fluorophore to KYF allows the synthesis of a fluorescent nanoemulsion that is suitable for biological imaging. The synthesis of the nanoemulsion is performed in an aqueous environment, and the KYF-Pt-NE forms via self-assembly of a short KYF peptide and an oleic acids-platinum(II) conjugate. The self-assembly process depends on the temperature of the solution, the molar ratio of the substrates, and the flow rate of the substrate addition. Crucial steps include maintaining the optimal stirring rate during the synthesis, permitting sufficient time for self-assembly, and pre-concentrating the nanoemulsion gradually in a centrifugal concentrator.

Introduction

In recent years, there has been a growing interest in the engineering of nanoparticles for such biomedical applications as drug delivery and bioimaging1,2,3,4. The multifunctionality of nanoparticle-based systems often necessitates incorporating multiple components within one formulation. The building blocks that are based on lipids or polymers often differ in terms of their physicochemical properties as well as their biocompatibility and biodegradability, which ultimately might affect the function of the nanostructure1

Access restricted. Please log in or start a trial to view this content.

Protocol

1. Synthesis of the Oleic Acids–Platinum(II) Conjugate

  1. Activation of cisplatin
    1. Suspend 50 mg (0.167 mmol) of cisplatin in 4 mL of water (e.g., nanopure) at 60 °C.
    2. Add dropwise 55.2 mg (0.325 mmol) of AgNO3 in 0.5 mL of water to the solution of cisplatin and stir the reaction for at least 2 h at 60 °C. The white precipitate of AgCl will form indicating the progress of the reaction.
    3. To determine if the activation reaction is completed, perform the test with 10% HCl for the presence of free Ag+ ion in solution. The test should be negative (no additional AgCl precipitate should form).
    4. ....

Access restricted. Please log in or start a trial to view this content.

Results

Representative TEM image of KYF-Pt-NE prepared using this protocol is shown in Figure 2A. The KYF-Pt-NEs are spherical in morphology, well dispersed, and uniform in size. The core diameter of the KYF-Pt-NEs, measured directly from three TEM images with a minimum of 200 measurements done, is 107 ± 27 nm. The hydrodynamic diameter of KYF-Pt-NE, analyzed using dynamic light spectroscopy (DLS), was found to be 240 nm with a polydispersity index of 0.156. The Zeta.......

Access restricted. Please log in or start a trial to view this content.

Discussion

Critical steps in the nanoemulsion synthesis include adjusting the molar ratio of the substrates, maintaining temperature and flow rate control during oleic acids–Pt(II) addition, providing sufficient time for self-assembly, and purifying the product using a centrifugal concentrator column. These parameters influence the size and morphology of the KYF-Pt-NE; thus, it is particularly important to maintain the proper molar ratio and adjust the synthetic conditions correctly.

The ratio of t.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

Authors do not have a conflict of interest to disclose.

Acknowledgements

We gratefully acknowledge financial support from the National Cancer Institute, grant SC2CA206194. No competing financial interests are declared.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
2-(1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium
tetrafluoroborate (TBTU)
ANASPEC INC.:AS-20376SPPS
4-well chamber confocal dishLab-Tek II, Thermo Fisher Scientific154526For imaging
6-bromohexanoic acidChem-Impex INT’L INC.24477Click modification for peptide
A2780Generously doanted by professor John Martignetti from The Mount Sinai HospitalOvarian cancer cell line
Barnstead NanopureThermo FisherD11901water filtration system
BUCHI rotavapor R-3BuchiZ568090For solvent removal and sample drying
Centrifuge 5810 Reppendorf5811FFor platinum complex separation
Cis-dichlorodiamineplatinum (II) 99%Acros Organics19376-0050in vitro tests
CP70Generously doanted by professor John Martignetti from The Mount Sinai HospitalOvarian cancer cell line
Digital water bathVWR97025-134For warming up media for cell culture
Dynamic Light Scattering (DLS)Brookhaven Instrument CorporationFor nanoparticle size measurments
ES-2ATCCCRL-1978ovarian cancer cell line
Fmoc-L-Lys(Boc)-OH 99.79%Chem-Impex INT’L INC.00493SPPS
Fmoc-L-Phe 4-alkoxybenzyl alcohol resin (0.382 meq/g),Chem-Impex INT’L INC.01914SPPS
Fmoc-LTyr(tBu)-OH 98%Alfa AesarH59730SPPS
HERACELL 150i CO2 incubatorThermo Scientific Fisherincubator
High pressure syringe pumpNew Era1010-USFor platinum complex addition in nanoparticle synthesis
Hotplate/stirrerVWR12365-382For sample stirring and heating
LAMP-1 Antibody(cojugated with Alexa Fluor 647)Santa Cruz Biotechnologysc-18821 AF647For imaging
N,N-diisopropylethylamine (DIPEA)Oakwood Chemical005027SPPS
Ninhydrin 99%Alfa AesarA10409Kaiser test
Oleic acidChem-Impex INT’L INC.01421For platinum complex synthesis
OV90ATCCCRL-11732Ovarian cancer cell line
PBSCorning21-031-CVFor cell wash
Permount mounting mediumFisher ChemicalSP15-100For imaging
PhenolFisher ChemicalA92500Kaiser test
Phosphotungstic acidFisher ChemicalA248-25negative stain for TEM
Piperidine 99%BTC219260-2.5LSPPS
Platinum AAS standard soultionAlfa Aesar880861000ug/ml for calibration curve
Propargyl bromide 97%Alfa AesarL10595For alkyne modification of fluoresceine
Scientific biological cabinetThermo Scientific Fisher1385Bio-hood for cell culture
Self-Cleaning Vacuum SystemWelch2028Vacuum pump for rotavapor
Silver nitrateAcros Organics19768-0250Cisplatin activation
SKOV3ATCCHTB-77Ovarian cancer cell line
Sodium hydroxideFisher ScientificS313-1For platinum complex synthesis
Tin (II) chlorideSigma Aldrich208256Test for Platinum presence
TOV21GATCCCRL-11730Ovarian cancer cell line
Trifluoroacetic acid 99% (TFA)Alfa AesarL06374SPPS
Triisopropylsilane (TIPS)Chem-Impex INT’L INC.01966SPPS
Triton-XSigma AldrichT8787-100MLFor imaging
Uranine powder 40%Fisher ScientificS25328AFor alkyne modification of fluoresceine
Vivaspin 20 (10000 MWCO)SartoriousVS2001For Nanoparticle wash and condensation
VWR Inverted MicroscopeVWR89404-462For cell culture monitoring

References

  1. Agrahari, V., Agrahari, V., Mitra, A. K. Nanocarrier fabrication and macromolecule drug delivery: challenges and opportunities. Therapeutic Delivery. 7 (4), 257-278 (2016).
  2. Anselmo, A. C., Mitragotri, S. Nanoparticles in the clinic. Bioengineering & Translat....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Tags

Oleic Acid Platinum ConjugateKYF Peptide CoatingSelf Assembly ProcessCentrifugal ConcentrationFluorescent NanoemulsionPlatinum ReleaseOvarian Cancer CellsTransmission Electron MicroscopySyringe Pump Method